All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...703Next →

hiv & aids news selected from other sources

  • The search for a cure
    HIV Antibodies Block Infection by Reservoir-Derived Virus in Laboratory Study
    National Institutes of Allergy and Infectious Diseases press release | 6 hours ago

    The researchers conclude that passive immunotherapy involving bNAbs individually or in combination may control HIV in the absence of antiretroviral therapy. A number of clinical trials are already underway or planned to test this hypothesis.

  • New and experimental hepatitis C treatment
    European Commission Approves Bristol-Myers Squibb’s Daklinza (daclatasvir) Across Multiple Genotypes for the Treatment of Chronic Hepatitis C Infection
    Bristol-Myers Squibb | 11 hours ago

    Bristol-Myers Squibb Company today announced that the European Commission has approved Daklinza (daclatasvir), a potent, pan-genotypic NS5A replication complex inhibitor (in vitro), for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 for the treatment of chronic hepatitis C virus (HCV) infection in adults. Daklinza, when used in combination with sofosbuvir (Sovaldi), is an all-oral, interferon-free regimen that provided cure rates of up to 100% in clinical trials

  • Policy
    The end of AIDS and the NGO Code of Conduct
    The Lancet | 13 hours ago

    In 2008, a consortium of concerned international NGOs and advocacy organisations introduced the NGO Code of Conduct for Health System Strengthening, which highlighted how disproportionate funding for NGOs, rather than for public sector health systems, has undermined public services in many developing countries.The NGO Code of Conduct outlines a set of proposed best practices for NGOs to support local public services. However, after promoting the NGO Code of Conduct for 5 years, the behaviour of some NGOs seems unlikely to change unless donors hold them accountable for adhering to these best practices.

  • Hepatitis B
    One out of 10 Asian Americans has hepatitis B
    Philippine Star | 14 hours ago

    There is a virus that is 100 times more easily transmitted than the dreaded acquired immunodeficiency syndrome virus, and it is called Hepatitis B Virus (HBV). HBV is a virus that can cause Chronic Hepatitis B, a life threatening liver disease. According to United States Center for Disease Control and Prevention (CDC), up to 25 percent of people with chronic hepatitis B develop serious liver problems such as liver failure, liver cancer and cirrhosis (severe liver scarring), if left untreated.One in 10 Asian Americans has HBV- a rate over 20 times higher than that of the overall U.S. population - two in three of whom are not aware of it.

  • Three Approaches to Beating the AIDS Epidemic in South Africa
    New York Times | 26 August 2014

    South Africa’s AIDS epidemic is at its worst in high-risk subgroups like gay men, prostitutes, truckers, prisoners, miners and patients who don’t take their drugs regularly. To have any hope of beating the epidemic, it must focus on such groups, experts say. Many pilot projects to do that have been started with aid from the United States government program called Pepfar. Here are some of them.

  • Epidemiology
    AIDS Progress in South Africa in Peril
    New York Times | 26 August 2014

    Now that aid pipeline is drying up as the program shifts its limited budget to poorer countries, so the South African government must find hundreds of millions of dollars, even as its national caseload grows rapidly.

  • PrEP
    AHF Campaigns Against PrEP as a 'Public Health Intervention'
    Poz magazine news | 26 August 2014

    The campaign is appearing in various outlets throughout August and will likely expand.

  • The search for a cure
    A voice for HIV cure: Scientists, activists gather for Hutch conference
    Fred Hutchinson Cancer Research Center press release | 26 August 2014

    Matt Sharp is no scientist. But when he joins researchers from around the country tomorrow for a conference on using gene therapy to cure HIV, he will bring a perspective that few others in the room can match.

  • Access to medicines and treatment
    Stock-out hits HIV treatment across India
    Times of India | 26 August 2014

    Treatment for HIV patients across India has taken a hit, especially in Delhi and Mumbai, due to severe stock-outs of life-saving medicines reported at government-owned centres.

  • New and experimental HIV treatments
    FDA Approves New Single-Tablet HIV Regimen, Triumeq | 26 August 2014

    The U.S. Food and Drug Administration (FDA) has approved Triumeq, ViiV Healthcare's single-tablet, triple-combination antiretroviral (ARV) regimen, as a first-line therapy to treat HIV. The tablet is comprised of the integrase inhibitor dolutegravir (Tivicay) plus abacavir and lamivudine (Kivexa/Epzicom) and is the first single-tablet regimen to receive approval that does not contain tenofovir.

← First12345...930Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.